Brown Advisory Inc Incyte Corp Transaction History

Brown Advisory Inc

$77.3 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 13, 2022	BUY	$66.18 - $83.18 $359,357 - $451,667	5,430 New	5,430 $412,000
Q2 2022 Aug 02, 2022	SELL	$66.18 - $83.18 $383,777 - $482,360	-5,799 Closed	0 $0
Q1 2022 Sep 13, 2022	BUY	$66.02 - $79.71 $382,849 - $462,238	5,799 New	5,799 $461,000
Q4 2020 Feb 12, 2021	SELL	$80.74 - $97.7 $182,956 - $221,388	-2,266 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$85.07 - $109.69 $55,550 - $71,627	-653 Reduced 22.37%	2,266 $204,000
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $15,874 - $23,311	-214 Reduced 6.83%	2,919 $303,000
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $17,248 - $23,469	-273 Reduced 8.02%	3,133 $230,000
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $584 - $765	-8 Reduced 0.23%	3,406 $297,000
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $582 - $692	8 Added 0.23%	3,414 $253,000
Q2 2019 Aug 12, 2019	SELL	$73.52 - $88.7 $10,954 - $13,216	-149 Reduced 4.19%	3,406 $289,000
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $12,521 - $17,369	197 Added 5.87%	3,555 $307,000
Q4 2018 Feb 13, 2019	BUY	$58.5 - $69.94 $196,443 - $234,858	3,358 New	3,358 $214,000
Q3 2018 Nov 13, 2018	SELL	$61.75 - $74.23 $200,749 - $241,321	-3,251 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$60.85 - $83.98 $34,988 - $48,288	-575 Reduced 15.03%	3,251 $217,000
Q1 2018 Jun 28, 2018	BUY	$83.06 - $100.98 $91,366 - $111,078	1,100 Added 40.35%	3,826 $318,000
Q1 2018 May 14, 2018	SELL	$83.06 - $100.98 $373,520 - $454,107	-4,497 Reduced 62.26%	2,726 $227,000
Q4 2017 Feb 12, 2018	BUY	$93.56 - $116.6 $10,291 - $12,826	110 Added 1.55%	7,223 $684,000
Q3 2017 Nov 13, 2017	SELL	$109.15 - $138.27 $256,939 - $325,487	-2,354 Reduced 24.87%	7,113 $830,000
Q2 2017 Aug 14, 2017	BUY	N/A	9,467	9,467 $1.19 Million

Others Institutions Holding INCY

# of Institutions

644

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.

Account